Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pachyonychia Congenita”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Not applicableStudy completedNCT00074685
What this trial is testing

National Registry for Ichthyosis and Related Disorders

Who this might be right for
Darier DiseaseHailey-Hailey DiseaseHyperkeratosis, Epidermolytic+4 more
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 610
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06545695
What this trial is testing

Epidermal Growth Factor Receptor Inhibition for Keratinopathies

Who this might be right for
Epidermolytic IchthyosisPalmoplantar KeratodermaPachyonychia Congenita
Northwestern University 44
Not applicableLooking for participantsNCT02321423
What this trial is testing

International Pachyonychia Congenita Research Registry

Who this might be right for
Pachyonychia Congenita
Pachyonychia Congenita Project 2,000
Large-scale testing (Phase 3)Study completedNCT04520750
What this trial is testing

VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita

Who this might be right for
Pachyonychia Congenita
Palvella Therapeutics, Inc. 36
Large-scale testing (Phase 3)Looking for participantsNCT05643872
What this trial is testing

A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita

Who this might be right for
Pachyonychia Congenita
Palvella Therapeutics, Inc. 45
Not applicableUnknownNCT01382511
What this trial is testing

Simvastatin Treatment of Pachyonychia Congenita

Who this might be right for
Pachyonychia Congenita
Tel-Aviv Sourasky Medical Center 10
Large-scale testing (Phase 3)Study completedNCT05180708
What this trial is testing

A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita

Who this might be right for
Pachyonychia Congenita
Palvella Therapeutics, Inc. 87
Early research (Phase 1)Study completedNCT02152007
What this trial is testing

Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)

Who this might be right for
Pachyonychia Congenita
TransDerm, Inc. 15
Early research (Phase 1)Study completedNCT05956314
What this trial is testing

Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC

Who this might be right for
Punctate Palmoplantar Keratoderma Type 1Pachyonychia Congenita
Kamari Pharma Ltd 18
Early research (Phase 1)Study completedNCT00716014
What this trial is testing

Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita

Who this might be right for
Pachyonychia Congenita
Pachyonychia Congenita Project 1
Testing effectiveness (Phase 2)UnknownNCT00936533
What this trial is testing

Botulinumtoxin A Treatment in Epidermolysis Bullosa Simplex and Pachyonychia Congenita

Who this might be right for
Epidermolysis Bullosa Simplex
Uppsala University 40
Early research (Phase 1)Study completedNCT02592954
What this trial is testing

Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin

Who this might be right for
Epidermolysis Bullosa SimplexPachyonychia Congenita
Johns Hopkins University 5
Early research (Phase 1)Study completedNCT05435638
What this trial is testing

Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases

Who this might be right for
Punctate Palmoplantar Keratoderma Type 1Pachyonychia Congenita
Kamari Pharma Ltd 14
Large-scale testing (Phase 3)Study completedNCT03920228
What this trial is testing

Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita

Who this might be right for
Pachyonychia Congenita
Palvella Therapeutics, Inc. 73